American Gene Technologies® Welcomes Barry H. Wells, M.D., as Head of Business Development

Published on :

American Gene Technologies, a clinical-stage biotechnology company based in Rockville, Maryland, has promoted Barry H. Wells, M.D. as head of business development. Dr. Wells joined the company’s investor relations team in 2019.

Prince William County Hires New Life Sciences Business Development Manager

Published on :

Prince William County Department of Economic Development (PWCDED) hired Helena Kondow-McConaghy, Ph.D. as Business Development Manager for the Life Sciences to recruit and retain businesses in the fastest growing biotechnology cluster in the Greater Washington, D.C. region.

Former Government Scientist Appointed First Leader of ARPA-H

Published on :

President Joe Biden on Monday appointed longtime biologist and former government scientist Renee Wegrzyn as the first director of the nascent Advanced Research Projects Agency for Health.
Biden’s announcement comes as ARPA-H advocates debate where the multibillion-dollar agency should be headquartered and which elusive disease areas should be prioritized. The president officially launched the agency in March with $1 billion in initial funding allotted by Congress, but the search for its inaugural director has taken months.
Wegrzyn, 45, currently works at Boston-based Ginkgo Bioworks, a company focused on biological engineering, but has prior experience in two government agencies Biden has said he hopes to emulate with ARPA-H — the Pentagon’s Defense Advanced Research Projects Agency and the Intelligence Advanced Research Projects Activity.

Deka Biosciences Appoints Chief Medical Officer and Vice President of Clinical Operations

Published on :

Deka Biosciences (“Deka”), a biotech company focused on the development of novel cytokine therapies to treat cancer and inflammatory diseases, announced today the appointment of Charlotte Moser, MD, PhD, MSc, MBA as Chief Medical Officer (CMO) and Deb Kientop, MBA as Vice President, Clinical Operations.

Zephyr AI Appoints Allen Hodge as Chief Commercial Officer

Published on :

Zephyr AI, Inc. (“Zephyr AI”), a high-growth healthcare technology company committed to radically reshaping traditional approaches to drug discovery precision medicine and predictive analytics has announced the appointment of Allen Hodge as Chief Commercial Officer. Hodge brings more than two decades of experience in building commercial organizations to this role. Prior to joining Zephyr AI, Hodge served as Senior Vice President and U.S. General Manager at BioCryst Pharmaceuticals, delivering a successful launch of Orladeyo for patients with hereditary angioedema.

Capsulomics Expands Leadership Team with Key Hires

Published on :

Capsulomics, Inc., a life sciences company focused on the development and commercialization of diagnostic solutions for cancer screening, prevention, and smarter treatment decisions, announced today the appointment of Stacey Gilbert as Vice President of Market Access and Reimbursement, and Lisa Kann as Vice President of Product Development and Strategy.

Aclaris Therapeutics Expands Leadership Team

Published on :

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced the appointment of Douglas Manion, M.D., FRCP (C), as President and Chief Operating Officer. Dr. Manion will be responsible for overseeing day-to-day operations, continuing to develop Aclaris’ infrastructure and helping Aclaris develop its vision and overall strategic direction alongside Neal Walker, Aclaris’ CEO, and Aclaris’ board of directors.

Ancora Heart Appoints Mark Miles as Chief Commercial Officer

Published on :

Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure (HF), today announced that Mark Miles has joined the company as Chief Commercial Officer (CCO). He will oversee commercialization strategy for the AccuCinch® Ventricular Restoration System, the only completely transcatheter procedure to treat the enlarged left ventricle for patients with symptomatic heart failure and a reduced ejection fraction (HFrEF), currently being evaluated in the CORCINCH-HF pivotal clinical trial.

Margia Argüello Joins Avalere Health  | A Member of Fishawack Health, as Consultant II, Senior Manager

Published on :

Before joining Avalere, Margia served as a senior business development manager for the Maryland Department of Commerce, attracting and retaining life sciences investments and businesses in the region. Prior, she served as associate director for the Office of Innovation Initiatives at Johns Hopkins, designing platforms for entrepreneurs and supporting Johns Hopkins Technology Ventures’ accelerator.